DK149893C - Analogifremgangsmaade til fremstilling af thiazolderivater eller farmaceutisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af thiazolderivater eller farmaceutisk acceptable salte deraf

Info

Publication number
DK149893C
DK149893C DK452273A DK452273A DK149893C DK 149893 C DK149893 C DK 149893C DK 452273 A DK452273 A DK 452273A DK 452273 A DK452273 A DK 452273A DK 149893 C DK149893 C DK 149893C
Authority
DK
Denmark
Prior art keywords
thiazold
analogue
derivatives
preparation
acceptable salts
Prior art date
Application number
DK452273A
Other languages
Danish (da)
English (en)
Other versions
DK149893B (da
Inventor
Toshihiko Hibino
Yoshio Suzuki
Shigeru Okano
Yoichi Hara
Etsuro Sato
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP47082574A external-priority patent/JPS5238559B2/ja
Priority claimed from JP48039354A external-priority patent/JPS49125359A/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of DK149893B publication Critical patent/DK149893B/da
Application granted granted Critical
Publication of DK149893C publication Critical patent/DK149893C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK452273A 1972-08-17 1973-08-16 Analogifremgangsmaade til fremstilling af thiazolderivater eller farmaceutisk acceptable salte deraf DK149893C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP8257472 1972-08-17
JP47082574A JPS5238559B2 (xx) 1972-08-17 1972-08-17
JP48039354A JPS49125359A (xx) 1973-04-05 1973-04-05
JP3935473 1973-04-05
ZA00741280A ZA741280B (en) 1972-08-17 1974-02-26 Thiazole derivatives
ZA7401280 1974-02-26

Publications (2)

Publication Number Publication Date
DK149893B DK149893B (da) 1986-10-20
DK149893C true DK149893C (da) 1987-04-21

Family

ID=27290112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK452273A DK149893C (da) 1972-08-17 1973-08-16 Analogifremgangsmaade til fremstilling af thiazolderivater eller farmaceutisk acceptable salte deraf

Country Status (10)

Country Link
US (1) US3932400A (xx)
CA (1) CA991640A (xx)
CH (1) CH581640A5 (xx)
DE (1) DE2341753C2 (xx)
DK (1) DK149893C (xx)
FR (1) FR2196162B1 (xx)
GB (1) GB1435139A (xx)
NL (1) NL179733C (xx)
SE (1) SE421615B (xx)
ZA (1) ZA741280B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
US4119718A (en) * 1977-05-02 1978-10-10 Merck & Co., Inc. 3-Amino-2-oxy-propoxy-substituted isothiazoles
US4260609A (en) * 1977-06-01 1981-04-07 Merck & Co., Inc. Di- and tri- substituted thiazoles
US4259341A (en) * 1977-06-01 1981-03-31 Merck & Co., Inc. Di- and tri-substituted thiazoles
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
GEP20084406B (en) * 2003-05-30 2008-06-25 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
AU2005308575A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidemia
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2007086980A2 (en) * 2005-11-10 2007-08-02 Duke University Methods of determining the risk of developing coronary artery disease
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CA2636077C (en) * 2006-01-18 2012-01-03 Amgen Inc. Thiazole compounds as protein kinase b (pkb) inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
CN101494980A (zh) * 2006-07-14 2009-07-29 兰贝克赛实验室有限公司 HMG-CoA还原酶抑制剂的多晶型形式及其应用
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2009011871A2 (en) * 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of pkb
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104530033B (zh) * 2014-12-26 2017-07-07 江西百神药业股份有限公司 一种盐酸阿罗洛尔的制备工艺新方法
CN105646472A (zh) * 2016-02-29 2016-06-08 山东齐都药业有限公司 一种盐酸阿罗洛尔的制备方法
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA599475A (en) * 1960-06-07 W. Harman Marion Aminoethylthiazoles
US2221147A (en) * 1938-11-18 1940-11-12 Goodrich Co B F Preparation of aminated esters of sulphydryl compounds
US3228952A (en) * 1962-06-27 1966-01-11 Dow Chemical Co Thiazole thioethers
US3158623A (en) * 1963-03-01 1964-11-24 Abbott Lab 5-nitro-2-furylthioamide
BE790569A (fr) * 1971-10-27 1973-04-26 Syntex Corp Agents cardiovasculaires a base de thiazoles

Also Published As

Publication number Publication date
NL179733C (nl) 1986-11-03
ZA741280B (en) 1975-03-26
CA991640A (en) 1976-06-22
DK149893B (da) 1986-10-20
NL7311248A (xx) 1974-02-19
US3932400A (en) 1976-01-13
GB1435139A (en) 1976-05-12
AU5928173A (en) 1975-02-20
DE2341753C2 (de) 1982-12-09
SE421615B (sv) 1982-01-18
FR2196162A1 (xx) 1974-03-15
FR2196162B1 (xx) 1977-01-28
NL179733B (nl) 1986-06-02
CH581640A5 (xx) 1976-11-15
DE2341753A1 (de) 1974-02-21

Similar Documents

Publication Publication Date Title
DK149893C (da) Analogifremgangsmaade til fremstilling af thiazolderivater eller farmaceutisk acceptable salte deraf
DK132119C (da) Analogifremgangsmade til fremstilling af cephalosporansyrederivater eller farmaceutisk acceptable salte deraf
DK145339C (da) Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf
DK149843C (da) Analogifremgangsmaade til fremstilling af 3-substituerede 4-fenylpiperidiner eller salte deraf med farmaceutisk acceptable syrer
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK143501C (da) Analogifremgangsmaade til fremstilling af beta-receptorblokerende derivater af 2-hydroxy-3-aminopropan eller terapeutisk anvendelige salte deraf
DK146538C (da) Analogifremgangsmaade til fremstilling af 7alfa-methoxycephalosporinderivater eller farmaceutisk acceptable salte deraf
DK157246C (da) Analogifremgangsmaade til fremstilling af n-acylamino-alfa-phenylacetamidocephalosporiner eller farmaceutisk acceptable salte heraf.
DK142948C (da) Analogifremgangsmaade til fremstilling af biphenylyl-acetylaminopyridiner eller fysiologisk acceptable salte heraf
DK138855C (da) Analogifremgangsmaade til fremstilling af penicilliner eller ikke-toksiske farmaceutisk acceptable salte deraf
DK153157C (da) Analogifremgangsmaade til fremstilling af 7-alfa-aminoacyl-3-halogen-cephalosporinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK149230C (da) Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf
DK136157B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-17beta-karboxylsyrederivater af androstanrækken eller salte deraf.
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK143105C (da) Analogifremgangsmaade til fremstilling af aminobenzocycloheptenderivater eller farmaceutisk acceptable additionssalte deraf
DK159267C (da) Analogifremgangsmaade til fremstilling af taurinderivater eller homotaurinderivater eller fysiologisk acceptable salte deraf
DK141875C (da) Analogifremgangsmaade til fremstilling af normorphinonderivater eller syreadditionssalte deraf
DK136468C (da) Analogifremgangsmade til fremstilling af 1-ethylimidazoler eller salte deraf
DK141728C (da) Analogifremgangsmaade til fremstilling af penicilliner eller ugiftige,pharmaceutisk acceptable salte deraf
DK142984C (da) Analogifremgangsmaade til fremstilling af benzobicycloalkanaminer eller farmaceutisk acceptable syreadditionssalte deraf
DK133153C (da) Analogifremgangsmade til fremstilling af tetrahydrocyklopropadibenzazepinderivater eller salte deraf
DK144656C (da) Analogifremgangsmaade til fremstilling af alkylphenylbenzopyranopyridiner eller pharmaceutiske acceptable salte deraf
DK139427C (da) Fremgangsmaade til fremstilling af benzensulfonylurinstoffer eller salte deraf
DK143104C (da) Analogifremgangsmaade til fremstilling af anilinophenylacetamidderivater eller salte deraf

Legal Events

Date Code Title Description
PUP Patent expired